Penn Medicine Provider
Urology
Phillip M. Pierorazio, MD
5.0
(449)
Accepting new patients
Sees patients age 18 and up
Penn Urology University City
View 2 additional locations
Make an appointmentCall 215-662-8699

About me

  • Chief, Section of Urology, Penn Presbyterian Medical Center
  • Professor of Surgery at the Hospital of the University of Pennsylvania

I am a board-certified urologist with training and expertise in urologic cancers.  I have expertise in all malignancies of the urinary tract, but my clinical and academic practice focuses on kidney cancer (renal cell carcinoma), testicular cancer (germ cell tumors), upper tract urothelial cancer, and prostate cancer.  I offer patients both open and minimally invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder, prostate, and retroperitoneal lymph node dissection for testicular cancer.  I am a firm believer that surgery is a last option and prefer non-operative management whenever possible – but routinely perform surgeries for complex cancers and patients. 

My research team includes basic science researchers, statisticians, and other urologists both inside and outside Penn Medicine.  We focus on cancer biomarkers, improving outcomes for complex surgeries, evaluating the quality of care through a cancer journey, and minimizing the impact of surgical treatments.  I run the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry - one of the largest active surveillance registries for patients with small kidney tumors. I am involved in a number of national guideline panels, including both the American Urological Association (AUA) and National Comprehensive Cancer Network (NCCN) Guidelines Committees, for Kidney, Testicular and Upper Tract Urothelial Cancer. 

While I experience tremendous satisfaction from generating research and guidelines that influence the care of cancer patients around the world, in my opinion, there is no greater impact in medicine than taking a patient through a cancer journey.  My greatest joy comes from the relationships we build through diagnosis, treatment, and the survivorship journey.

Education and training

  • Medical School: Columbia University
  • Residency: Johns Hopkins Hospital

What my patients think about me

Average Rating
5.0

455 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
knowledgeable
June 2025
5.0
5.0
excellent service
May 2025
5.0
5.0
expertise
May 2025
5.0
5.0
great dr

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Pierorazio is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

My research

Raver M, Ahmed M, Okhawere KE, Saini I, Chaturvedi R, Patel M, Sauer Calvo R, Soputro NA, Ramos R, Billah M, Crivellaro S, Mansour AM, Kaouk J, Singla N, Porter J, Abaza R, Bhandari A, Hemal AK, Pierorazio PM, Chung BI, Rogers CG, Mehrazin R, Badani K, Stifelman M. Adoption of Single-Port Robotic Partial Nephrectomy Increases Utilization of the Retroperitoneal Approach: A Report from the Single-Port Advanced Research Consortium. , J Laparoendosc Adv Surg Tech A. 2025 Feb;35(2):131-137. doi: 10.1089/lap.2024.0305. Epub 2025 Feb 6. PMID: 39909473: 2025

Gilligan T, Lin DW, Adra N, Bagrodia A, Feldman DR, Yamoah K, Aggarwal R, Chandrasekar T, Costa D, Drakaki A, Eggener S, Emamekhoo H, Geynisman DM, Graham L, Humphrey P, Leuva H, Levine EG, Luckenbaugh A, Maughan BL, McGregor B, Monk P, Picus J, Pierorazio P, Rais-Bahrami S, Reichert Z, Rwigema JC, Saylor P, Shah A, Shah S, Singla N, Sircar K, VanderWeele D, Zhumkhawala A, Montgomery S, Sliker B. NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025. , J Natl Compr Canc Netw. 2025 Apr;23(4):e250018. doi: 10.6004/jnccn.2025.0018. PMID: 40203876: 2025

Hu B, Alsyouf M, Farkouh A, Cary C, Masterson T, Einhorn L, Adra N, Boorjian SA, Kollmannsberger C, Schuckman A, So A, Black PC, Bagrodia A, Skinner E, Alemozaffar M, Brand T, Eggener S, Pierorazio P, Stratton K, Nappi L, Nichols C, Daneshmand S. Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial. , J Urol. 2025 Apr 9:101097JU0000000000004561. doi: 10.1097/JU.0000000000004561. Online ahead of print. PMID: 40203124: 2025

Cortese BD, Alkhatib KY, Harmatz IM, Michel KF, Lee DJ, Guzzo TJ, Vaughn DJ, Moses KA, Pierorazio PM, Talwar R. . The impact of telemedicine on racial and ethnic disparities in oncologic care during the COVID-19 pandemic , Am J Cancer Res. 2025 Mar 15;15(3):1224-1233. doi: 10.62347/RNJS4301. eCollection 2025. PMID: 40226475 Free PMC article.: 2025

Lattanzio K, Alkhatib K, Guzzo T, Lee DJ, Pierorazio P, Bivalacqua T, Schurhamer B. . Case study: Pulsed electric field ablation for salvage prostate cancer ablation , Urol Case Rep. 2025 Mar 25;60:103023. doi: 10.1016/j.eucr.2025.103023. eCollection 2025 May.PMID: 40270519 Free PMC article.: 2025

Pallauf M, Rezaee M, Elias R, Wlajnitz T, Fletcher SA, Cheaib J, Alkhatib K, Chang P, Wagner AA, McKiernan JM, Allaf ME, Pierorazio PM, Singla N. Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance. , BJU Int. 2025 Jan 28. doi: 10.1111/bju.16651. Online ahead of print. PMID: 39873312: 2025

Alkhatib KY, Cheaib JG, Pallauf M, Alam R, Patel HD, Wlajnitz T, Singla N, Chang P, Wagner AA, Pavlovich CP, McKiernan JM, Guzzo TJ, Allaf ME, Pierorazio PM. Active Surveillance versus Primary Intervention for Clinical T1a Kidney Tumors: Twelve-Year Experience of the DISSRM Prospective Comparative Study. , J Urol. 2025 Apr 22:101097JU0000000000004583. doi: 10.1097/JU.0000000000004583. Online ahead of print.PMID: 40262276: 2025

Lane BR, Cheaib JG, Boynton D, Pierorazio P, Noyes SL, Peabody H, Singla N, Johnson A, Ghani KR, Krumm A, Singh K. Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancer. , Urol Oncol. 2024 May 3:S1078-1439(24)00429-0. doi: 10.1016/j.urolonc.2024.04.007. Online ahead of print. PMID: 38704319 : 2024

Harmatz IM, Alkhatib KY, Leff M, Nolazco JI, Michel KF, Slinger M, McLauchlan N, Cortese BD, Roberson DS, Schurhamer B, Lee DJ, Malkowicz SB, Trinh QD, Bivalacqua TJ, Guzzo TJ, Pierorazio PM. Prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey. , Urol Pract. 2024 Apr 2:101097UPJ0000000000000553. doi: 10.1097/UPJ.0000000000000553. Online ahead of print. PMID: 38564816: 2024

Parmar M, Pierorazio PM. Maintaining Mental Health: Mindfulness Techniques for Clinicians. , Eur Urol Oncol. 2024 Dec;7(6):1183-1184. doi: 10.1016/j.euo.2024.09.019. Epub 2024 Oct 20. PMID: 39428279: 2024

View all publications